Ghjacumu Ghjuvan

Nirmal Kumar Shackleford

Mehdi Sampathkumar

Laure Hichor

Delphine Weill

Ludmila Meffre

Ingrid Juricek

Aline Laurendeau

Nicolas Chevallier

Frédérique Ortonne

Larousserie

Ghjacumu Ghjuvan'

Shackleford

Nirmal Kumar Sampathkumar

Mehdi Hichor

Laure Weill

Delphine Meffre

Ludmila Juricek

Ingrid Laurendeau

Aline Chevallier

Nicolas Ortonne

Frédérique Larousserie

Marc Herbin

Ivan Bièche

Xavier Coumoul

Mathieu Beraneck

Etienne-Emile Baulieu

Frédéric Charbonnier

Eric Pasmant

Charbel Massaad
email: charbel.massaad@parisdescartes.fr

Etienne-Emile Pr

Baulieu

The Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesis

Keywords: AHR, Myelin, Nerve, MPNST, neurofibroma, Wnt/ beta catenin

à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

ABSTRACT

Arylhydrocarbon receptor (AHR) is a ligand activated transcription factor involved in xenobiotic metabolism. Plexiform neurofibromas (PNF) can transform into malignant peripheral nerve sheath tumors (MPNSTs) that are resistant to existing therapies. These tumours are primarily composed of Schwann cells. In addition to NF1 gene inactivation, further genetic lesions are required for malignant transformation. We have quantified the mRNAs expression levels of AHR and its associated genes in 38 human samples. We report that AHR and the biosynthetic enzymes of its endogenous ligand are overexpressed in human biopsies of PNF and MPNST. We also detect a strong nuclear AHR staining in MPNST. The inhibition of AHR by siRNA or antagonists, CH-223191 and trimethoxyflavone, induces apoptosis in human MPNST cells. Since AHR disregulation is observed in these tumors, we investigate AHR involvement in Schwann cell physiology. Hence, we studied the role of AHR in myelin structure and myelin genes regulation in Ahr -/-mice during myelin development. Ahr ablation leads to locomotion defects and provokes thinner myelin sheaths around the axons. We observe a disregulation of myelin genes expression, and myelin developmental markers in Ahr -/-mice. Interestingly, AHR does not directly bind to myelin gene promoters. The inhibition of AHR in vitro and in vivo increased β-Catenin levels and stimulated the binding of β-Catenin on myelin gene promoters. Taken together, our findings reveal a new endogenous role of AHR in peripheral myelination, and in peripheral nerve sheath tumors. Finally, we suggest a potential therapeutic approach by targeting AHR in nerve tumors.

Significance statement

Aryl hydrocarbon receptor (AHR) is well known to mediate xenobiotic metabolism in vertebrates. Growing evidences reveal that AHR seems to have endogenous roles in the development and functioning of different organs. In our current study, we describe a novel role of AHR in peripheral myelination and in nerve sheath tumours. We show that AHR pathway is disregulated in human biopsies of nerve tumours. The blockade of AHR provokes cell death in nerve tumours, suggesting a new therapeutic avenue in the treatment of this invasive cancer. Furthermore, the inhibition of AHR in mice provokes locomotor defects and alteration of myelin structure. This work unravels a new endogenous role of AHR in peripheral myelination and a potential treatment of nerve tumours.

INTRODUCTION

Neurofibromatosis type 1 (NF1, #MIM162200) is an autosomal dominant neuro-cutaneous tumor predisposition syndrome caused by germline heterozygous mutation in the NF1 gene [START_REF] Friedman | Epidemiology of neurofibromatosis type 1[END_REF].

The most common NF1-associated tumors are benign peripheral nerve sheath tumors called neurofibromas which may be dermal or plexiform [START_REF] Sabbagh | Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1[END_REF]. Dermal neurofibromas are typically small and grow as discrete lesions in the dermis whereas plexiform neurofibromas (PNF) can develop internally along the plexus of major peripheral nerves and become quite large. PNFs can undergo transformation to malignant peripheral nerve sheath tumors (MPNSTs) in about 10% of NF1 patients [START_REF] Tucker | Association between benign and malignant peripheral nerve sheath tumors in NF1[END_REF]. MPNSTs are resistant to conventional therapies, and their deep-seated position and locally invasive growth hinder complete surgical resection with high degree of relapse rendering new treatments highly indispensable. Peripheral nerve Schwann cells (SCs) are the primary pathogenic cells in neurofibromas and MPNSTs, as bi-allelic mutation or loss of the NF1 gene occurs uniquely in tumor SCs [START_REF] Serra | Confirmation of a double-hit model for the NF1 gene in benign neurofibromas[END_REF]. NF1 encodes the RAS-GAP (Rat sarcoma GTPase activating protein) neurofibromin, and RAS signaling is elevated in neurofibroma SCs [START_REF] Cichowski | NF1 tumor suppressor gene function: narrowing the GAP[END_REF]. Neurofibromas may develop from SCs or Schwann cell progenitors (SCPs) due to the inactivation of Nf1 at the SCP stage or in adult mice [START_REF] Chen | Cells of Origin in the Embryonic Nerve Roots for NF1-Associated Plexiform Neurofibroma[END_REF] [START_REF] Wu | Plexiform and Dermal Neurofibromas and Pigmentation Are Caused by Nf1 Loss in Desert Hedgehog-Expressing Cells[END_REF].

Schwann cells (SC) carry out the myelination of axons in the nerve [START_REF] Garbay | Myelin synthesis in the peripheral nervous system[END_REF]. Myelin is essential for rapid action potential propagation along the axons [START_REF] Nave | Myelination of the Nervous System: Mechanisms and Functions[END_REF]. Peripheral myelin genes expression (Myelin Protein Zero (P0) and Peripheral Myelin Protein-22 (PMP22)) is tightly regulated in SC [START_REF] Niemann | Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease[END_REF]. Krox20 [START_REF] Topilko | Krox-20 controls myelination in the peripheral nervous system[END_REF], Wnt/β-Catenin signaling pathway [START_REF] Tawk | Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis[END_REF] are known positive regulators of myelin gene expression, whereas Sox2 [START_REF] Le | Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination[END_REF] and LXR [START_REF] Makoukji | Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols[END_REF] exert a negative effect.

Little is known of the additional cooperating genetic events potentially required for full plexiform neurofibroma's malignant transformation. Previous researches from our laboratory and others have shown an activation of the Wnt signaling pathway, during malignant transformation of plexiform neurofibromas to MPNSTs [START_REF] Quintana | Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor[END_REF][START_REF] Watson | Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance[END_REF]. Indeed, Wnt pathway is a common conjuncture between myelin development as well and malignant transformation. There is a growing evidences that over-activation of AHR (aryl hydrocarbon receptor) signaling pathway can alter Wnt/β-Catenin signaling in development, different human cancers and disease [START_REF] Huang | The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydrocarbon receptor nuclear translocator specify GABAergic neuron cell fate in C. elegans[END_REF][START_REF] Opitz | of the human aryl hydrocarbon receptor[END_REF].

AHR is a ligand-activated transcription factor that is best known for mediating the toxicity and tumor-promoting properties of the carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), commonly referred to as dioxin. The activation of AHR provokes its heterodimerisation with AHR Nuclear Translocator (ARNT). They bind specific responsive elements called Xenobiotic responsive elements (XREs), located in the promoter regions of the target genes and consequently, leading to their transactivation (e.g. Cytochrome 1A1). Nevertheless, its endogenous functions begin to emerge [START_REF] Long | MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice[END_REF] and natural ligands of the AHR, like tryptophan derivatives, were identified.

The AHR is present in ancient invertebrate organisms like C. elegans, where it is responsible for the regulation of GABAergic neuron fate specification [START_REF] Huang | The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydrocarbon receptor nuclear translocator specify GABAergic neuron cell fate in C. elegans[END_REF]. Kynurenine is a tryptophan catabolite generated via Tryptophan Dioxygenase (TDO) and Indoleamin 2,3-Dioxygenases (IDO). By activating AHR, kynurenine promotes tumor-cell survival and malignancy of glioma [START_REF] Opitz | of the human aryl hydrocarbon receptor[END_REF]. Despite the discovery of the cognate ligand of AHR, the endogenous role of the AHR remains poorly explored, especially in the peripheral nervous system.

In this study, we report an upregulation of AHR signaling in PNF and MPNST. Furthermore, the inhibition of AHR promotes MPNST cell apoptosis. On the other hand, we investigate the role of AHR in normal Schwann cell physiology and myelin genes regulation using Ahr-/-mice. These mice have thinner myelin sheaths, dysregulated myelin genes expression, and consequent locomotor deficiencies. Taken together, our results elicit a novel role of the AHR in peripheral myelin genes regulation and a stimulation of AHR activity in malignant transformation of peripheral nerve sheath tumors. Our results also suggest that targeting AHR could be a promising avenue in the treatment of PNF and MPNST.

RESULTS

AHR signaling pathway is activated in peripheral nerve sheath tumorigenesis

In a series of 38 tumors, we first analyzed mRNA expression of AHR, AHRR (AHR Repressor), and ARNT (Table 1). AHR was significantly up-regulated in plexiform neurofibromas (7-fold) and in MPNSTs (9-fold), compared to the dermal neurofibromas.

AHRR was significantly down-regulated in plexiform neurofibromas (3-fold) and MPNSTs (2-fold) compared to the dermal neurofibromas, while ARNT expression was not significantly altered in either the plexiform neurofibromas or the MPNSTs.

Several genes implicated in AHR pathway were also tested, including kynurenine metabolism (IDO1, IDO2, and TDO2), inflammation and immune pathways (IL1ß, IL6, IL8, CXCL5, and CXCL6), SC markers (S100B, and P0) and the proliferation (MKI67). IDO1, and TDO2 (but not IDO2) were significantly up-regulated in plexiform neurofibromas and in MPNSTs. Concerning the inflammatory pathway: IL1ß, IL6, IL8, CXCL5, and CXCL6 mRNA levels showed significant overexpression in plexiform neurofibromas and in MPNSTs, compared to the dermal neurofibromas (Table 1). It is noteworthy that AHR and the enzymes of its endogenous ligands are remarkably higher in MPNSTs than in PNFs. The proliferation-associated gene MKI67 was overexpressed in the MPNSTs. SC-specific genes (S100B, P0) expression was shown to be significantly down-regulated in MPNSTs.

We also performed an immunostaining of AHR in MPNST (Fig. 1). We detected strong nuclear AHR staining in a proportion of tumor cells, while intra-tumoral vessels and fibroblasts in a fibrous septum (taken as internal negative controls) were not stained.

Altogether, our data show that AHR pathway is activated in human PNFs and MPNSTs.

AHR inhibition induced apoptosis in MPNST cell lines.

As we observed AHR pathway is activated in human plexiform neurofibromas and MPNSTs. Subsequently, we hypothesized that inhibiting the AHR could affect MPNST cell survival. We used two AHR antagonists (CH and TMF) to inhibit AHR activity in STS26T.

Treatment with CH-223191 (50µM at 48h and 72h) modestly increased cell death and enhanced apoptosis and shifted to late apoptotic state (Double positive for both Annexin and PI cell population) as quantified by Annexin V and PI staining (Fig. 2A: 48 h, and Fig. 2B: 72 h; Fig. S1A). CH did not have any effect at 10 µM, whereas TMF exhibited a more potent effect on MPNST cell death even at 10 µM. TMF (10µM, 48h or 72h) decreased cell viability by approximately 50%. After incubation with TMF (10µM, 72h), approximately 20% of the cells underwent apoptosis and 30% were late apoptotic. As expected, CH-223191 and TMF inhibited the expression of AHR target gene: CYP1A1 (Fig. 2C). To confirm that this is due to AHR inhibition, we silenced AHR by siAHR. AHR silencing also induced apoptosis in STS26T dose dependently (Fig 2D). Silencing of AHR drastically decreased the mRNA levels of AHR and its target genes CYP1A1 and CYP1B1 (Fig. 2E). As the IL1ß expression was enhanced in plexiform neurofibromas and MPNSTs (Table 1), accordingly the inhibition of AHR either by siRNA or antagonists reduced IL1ß expression in STS26T cells (Fig. 2F).

We confirmed these results using another MPNST cell line, 90-8. As expected, CH inhibited the expression of the classical AHR target genes: CYP1A1 and CYP1B1 (Fig. S2A).

Treatment with CH (50µM) increased the number of dead cells (Fig. S2B, SC) and enhanced apoptosis. We confirmed this result with siAHR (Fig S2D ,S2E). Furthermore, it also reduced the expression of IL1ß (Fig. S2G).

Ahr ablation in mice caused locomotor defects and led to thinner myelin sheath.

Given the fact that PNF and MPNST is a complex tumor with different cells, we analyzed the expression of AHR and related components in different cells like Schwann cells, mast cells and endothelial cells. AHR mRNA is predominant in Schwann cells and may suggest its importance in Schwann cells physiology (Table 2). The observed activation of AHR pathway and the down-regulation of myelin gene (P0) and as well as S100B in plexiform neurofibromas and MPNSTs compelled us to investigate further the role of AHR in normal Schwann cells. Henceforth, we analyzed AHR expression in sciatic nerves and Schwann cells (Fig. 3A -C). AHR is expressed in the nerve (Fig. 3A,C) and is localized in the nucleus of SC as well as the perinuclear compartment (Fig. 3B).

We analyzed the locomotor behavior of Ahr -/-. We measured stride time using a motorized treadmill (Fig. 3D). No significant difference was observed with treadmill speed at 10 cm/s. However, when treadmill speed was increased at 16 cm/s, Ahr -/-mice showed slower stride than WT. At higher speed, Ahr -/-mice were not able to maintain the rhythm and therefore could not be tested.

Mice were then subjected to fixed speed rotarod protocol (14 rpm) for five consecutive days where the time to withstand the rotating rod was measured (Fig. 3E). The WT mice significantly improved their performance over days indicating an amelioration of their motor coordination, whereas the time latency of Ahr -/-mice remained constant. Indeed, WT mice were able to stay on the rotating bar on day 5 while Ahr -/-mice remained only. Our findings suggest that the Ahr -/-have impaired locomotion and motor coordination. Then, we performed the static rod test (Fig. 3G). All WT mice stayed 100s on the bar. In contrast, Ahr - /-mice were unsuccessful in staying (Fig. 3H). Finally, motor performance was evaluated using a dynamic rod test. The Ahr -/-mice were 3-times slower than the WT mice in crossing the rod (Fig. 3I). The Ahr -/-mice also exhibited more faults while crossing the rod (Fig 3I).

We studied myelin structure by electron microscopy. The myelin sheath of Ahr -/-mice was significantly thinner than controls (Fig. 3J,3K) and the axonal perimeter was higher in Ahr -/- mice compared to controls (Fig. 3L). We plotted the g-ratios of sciatic nerve fibers as a function of their respective axonal perimeters (Fig. 3M). We observed reduction in myelin thickness for all axon calibers, but smaller axons were more affected.

Western blot showed significant increase of P0 and PMP22 in Ahr -/-sciatic nerves (Fig. 3N).

Consistent with these results, the expression of the negative regulator of myelination, Sox2, was reduced by 40% in Ahr -/-mice (Fig. 3N), while the expression of active β-Catenin was enhanced by 2-fold and total β-Catenin was decreased by 40%. Therefore, the ratio active β-Catenin over total β-Catenin is increased by 3.5-fold in in Ahr -/-mice suggesting an activation of the Wnt/β-Catenin pathway.

Ahr is involved in myelination during development

To determine when these myelin abnormalities arose, we analyzed the expression pattern of AHR during the myelination process at P7, P21 and in 8-weeks old mice and compared it to the expression of positive modulators of myelination process: Krox20 and β-Catenin. As depicted in figure 4A, AHR expression was at the highest level at P7 and then decreased at later time points to reach its lowest level in adult mice. Krox20 expression gradually increased during the myelination process to attain the highest level at P21 and, as expected, dropped in adult animals. Finally, β-Catenin increased at P21, and then its expression was brought back to the same levels of P7 and at 8WO. Taking account of this difference in AHR expression during development, we analyzed structure of myelin sheaths from sciatic nerves of P7 mice (Fig. 4B). We observed a mild disorganization of myelin sheaths in Ahr -/-mice without affecting the g-ratio (Fig. 4C) or axonal perimeter (Fig. 4D). Nevertheless, Ahr -/-mice displayed fewer myelinated axons (28.88±1.18 for WT vs 20.88±1.23 for Ahr -/-, Fig. 4E). P0 (-50%) and PMP22 (-60%) protein expression was decreased in 7-days-old Ahr -/-mice (Fig. 4F). To explore if myelin gene inhibition is due to a dysregulation in the expression of the major transcriptional regulators of SC myelination, we quantified the expression of Sox2, Krox20, total β-Catenin and active β-Catenin. The knockout of Ahr did not affect the expression of Sox2. However, we observed a decreased Krox20 expression (-60%) that was confirmed by IHC experiments. We observed a 25% reduction of the number of Krox20 positive cells in the sciatic nerves as suggested by DAPI staining (Fig. 4G). Furthermore, WB analyses showed that active β-Catenin expression was diminished by 30% in Ahr -/-nerves (Fig. 4F). As the amount of total β-Catenin is increased in Ahr -/-mice (+35%), we observed a decrease of the ratio of active β-Catenin over total β-Catenin suggesting an impairment of the Wnt/β-Catenin pathway at P7 when Ahr is knocked out. At P21, electron microscopy images revealed that myelin sheaths are affected by the deletion of Ahr (Fig. 4H). The g-ratio was decreased designating thicker myelin sheaths around the axons of Ahr -/-mice (Fig. 4I). The axonal perimeter was reduced (Fig. 4J) while the numbers of myelinated were not affected in Ahr -/-mice (Fig. 4K).

At P21, P0 and PMP22 expression were stimulated by 2-fold in Ahr -/-mice. Sox2 expression was not still affected, while the expression of all the positive regulators was activated in Ahr - /-mice: Krox20 (+50%), total β-Catenin (+60%) and active β-Catenin (+35%) (Fig. 4L).

Altogether, our data point-out a crucial and differential role of Ahr during myelination process and highlight that Ahr knockout leads to defects in myelin sheaths.

AHR regulates myelin gene expression in Schwann Cells

We transfected MSC80 cells with either non-targeting siRNA (NT) or siAhr. First, the efficacy of the knock-down was evaluated by RT-qPCR (Fig. S3A) and western blot (Fig. S3B). In addition, we assessed the functional efficacy of the siAhr on Cyp1A1-Luciferase activity that was reduced drastically (-80%) (Fig. S3C). The knock-down of Ahr increased mRNA levels of P0 and PMP22 by 50% (Fig. 5A) and the promoter activity of P0 as well as PMP22 (Fig 5B ). Taken together, the silencing of Ahr in SC line or its knockout in mice led to a disregulation of myelin gene expression.

Then, we examined the mechanism by which the AHR regulates myelin gene expression. We identified by MatInspector software four potential binding sites for AHR on the level of P0 promoter and one putative AHR binding site on Pmp22 promoter (Fig. 5C).

Therefore, we tested the AHR binding on P0 and Pmp22 promoters by ChIP. As a positive control, we assayed the binding of the AHR on the level of its target gene: Cyp1A1 promoter.

As expected the AHR bound to Cyp1A1 promoter (Fig. 5D). This binding was enhanced by 2-fold after treatment with TCDD (100nM; 1h). However, we did not detect AHR interaction with any of the putative binding sites identified on Pmp22 (Fig. 5E) and P0 (Fig. 5F), even after the incubation of MSC80 with TCDD (loading control: Fig. S4A). These data showed that AHR does not seem to interact directly with myelin gene promoters.

The other possible mechanism of action of AHR is the cross-talk with another signaling pathway. We previously showed that activated Wnt/β-Catenin pathway enhances the expression of peripheral myelin genes [START_REF] Tawk | Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis[END_REF]. Furthermore, we demonstrated that the knocking-out Ahr in mice altered β-Catenin expression in the sciatic nerve (Fig. 3N).

Therefore, we addressed the question whether the action of AHR is mediated by Wnt/β-Catenin pathway. After silencing Ahr in MSC80 cells, we observed a 50% increase in the protein levels of active β-Catenin and a 30% increase of total β-Catenin levels (Fig. 5G). Furthermore, to support the hypothesis, knock down of Ahr led to a significant stimulation of mRNA expression levels of Wnt signaling components: Lrp6, Dvl2, Dvl3, Axin2 (Fig. 5H). Then, we assayed the functionality of the Wnt/β-Catenin pathway. The SuperTOP Flash-Luciferase construct, bearing several binding sites for TCF/LEF, was activated by 2.5fold 48h after siAhr (Fig. 5I). To assess how AHR modifies β-Catenin levels in MSC80 cells, we assumed that AHR is able to interact with β-Catenin and stimulates its degradation as described in intestine cancer cells [START_REF] Kawajiri | Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands[END_REF]. Immunoprecipitation of AHR indicated proteinprotein interaction of β-Catenin and AHR in MSC80 cells (Fig. 5J).

Consequently, we hypothesized that the knock-down of Ahr increases the recruitment of β-Catenin with TCF/LEF complex on the level of myelin genes promoters. We localized LEF/TCF-β-Catenin binding sites on P0 and PMP22 promoters (12) (Fig. 5K). ChIP assays with β-Catenin antibodies showed that Ahr silencing increased the recruitment of β-Catenin on P0 (Fig. 5L, loading control: Fig. S4B) and Pmp22 promoters (Fig. 5M, Fig. S4B).

Moreover, the binding of β-Catenin was also enhanced after Ahr silencing on the level of a Wnt target gene, Axin2 (Fig. S4C). GAPDH was used as a negative control (Fig. S4D).

Collectively, these data demonstrate that AHR exerts its effect on myelin genes through Wnt/β-Catenin pathway.

DISCUSSION

We reveal that AHR plays a crucial role in myelination process of the nerve and is overexpressed in nerve tumors. In a series of NF1-associated nerve sheath tumors we demonstrated that AHR signaling pathway is activated. We further analyzed other genes linked to the AHR and involved in tryptophan metabolism that lead to the synthesis of kynurenine, an endogenous ligand of AHR [START_REF] Opitz | of the human aryl hydrocarbon receptor[END_REF][START_REF] Mezrich | An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells[END_REF][START_REF] Zhai | The role of IDO in brain tumor immunotherapy[END_REF]. The expression of two genes participating to the first steps of tryptophan metabolism, namely IDO1 and TDO2, was significantly increased in plexiform neurofibromas and MPNSTs. IDO1 and TDO2 found to be remarkably increased in malignant form compared to the benign form of these tumors suggesting an increased AHR activity in the malignant transformation. The enzyme IDO1 mediates the first, rate-limiting, step in tryptophan metabolites to kynurenine, and is upregulated under an inflammatory microenvironment [START_REF] Litzenburger | Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR[END_REF]. Through generation of downstream metabolites, IDO1 enzyme activity may affect immunity, including specific immunomodulatory or cytotoxic functions [START_REF] Mezrich | An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells[END_REF]. It has been reported that L-kynurenine activates AHR [START_REF] Opitz | of the human aryl hydrocarbon receptor[END_REF], which positively regulates IDO1 expression in immune cells such as dendritic cells. Our observation showing a progressive up-regulation of IDO1 and TDO2 in plexiform neurofibromas (3-fold and 5-fold), and a further stimulation in MPNSTs (50-fold and 25-fold) suggests that kynurenine synthesis leading to AHR activation may play a role in peripheral nerve sheath tumor progression to malignancy.

In addition to the biallelic inactivation of the NF1 gene, supplemental genetic lesions are necessary for malignant progression of plexiform neurofibromas. Alterations of additional genes (CDKN2A/B, TP53, SUZ12, EED) were detected in MPNSTs (3 24),. We have previously shown that Wnt/β-Catenin pathway was dysregulated in MPNSTs [START_REF] Luscan | The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis[END_REF], and the present study reveals that AHR pathway is also activated in these tumors. Furthermore, we have described an elevation of Wnt5a [START_REF] Luscan | The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis[END_REF] and AHR expression in MPNST tumours.

Conversely, the knock-down of AHR in MPNST cells inhibits Wnt5a expression (not shown). Therefore, our data suggest a possible link between AHR and Wnt/β-Catenin pathways in MPNST.

Consequently, we inhibited AHR in MPNST cell lines to alter their survival. Both AHR antagonists (CH-223191 or TMF) and siAHR induced apoptosis of two MPNST cell lines: 90-8 and STS26T. Again, this observation highlights the importance of AHR in SC malignancy in addition to NF1. Furthermore, AHR inhibition could down-regulate IL1ß that was elevated in MPNST tumors. Previous results suggested that AHR activation coupled with inflammatory signals can lead to synergistic induction of IL6 expression in tumor cells [START_REF] Dinatale | Mechanistic insights into the events that lead to synergistic induction of interleukin 6 transcription upon activation of the aryl hydrocarbon receptor and inflammatory signaling[END_REF]. We revealed a significant increase of IL1ß, IL6, IL8, CXCL5, and CXCL6 mRNA levels in plexiform neurofibromas and MPNSTs. These results confirm previous in vitro findings showing that AHR activation may promote the induction of IL6, and IL8 [START_REF] Kolasa | AhR-and NF-κB-dependent induction of interleukin-6 by co-exposure to the environmental contaminant benzanthracene and the cytokine tumor necrosis factor-α in human mammary MCF-7 cells[END_REF][START_REF] Vogel | Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-κB[END_REF], ), and highlight the implication of the AHR in the regulation of inflammation pathway [START_REF] Hollingshead | Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells[END_REF].

Previous studies from our laboratory and other have shown that some signaling pathways that are involved in myelination process (Wnt/ β-Catenin, mTOR, ERK) ,ironically or unfortunately, are deregulated in MPNST (, , (30, 31), 32). Therefore, we then enquired about the endogenous role of AHR in normal Schwann cell physiology and peripheral nerve myelination. We revealed that AHR is expressed in SC and in the sciatic nerve. We then revealed that Ahr -/-mice present an alteration in locomotion. Additionally, electron microscopy analyses depicted thinner myelin sheaths. These data unveil the role of the AHR on SC myelinating functions. Prenatal exposure of TCDD in rats provoked a delay in oligodendrocyte differentiation and maturation [START_REF] Fernández | A single prenatal exposure to the endocrine disruptor 2,3,7,8-tetrachlorodibenzo-p-dioxin alters developmental myelination and remyelination potential in the rat brain[END_REF]. TCDD could also disrupt the functions of AHR to provoke neuropathies. In fact, rats intoxicated by TCDD showed severe defects in myelin structure of tibial and sciatic nerve and reduction in nerve conduction velocity [START_REF] Grehl | Histologic evidence for a toxic polyneuropathy due to exposure to 2,3,7,8 -tetrachlorodibenzo-p-dioxin (TCDD) in rats[END_REF][START_REF] Grahmann | Electrophysiologic evidence for a toxic polyneuropathy in rats after exposure to 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD)[END_REF]. Our results not only reinforce the endogenous role of AHR in normal myelination process, but also the mechanism by which it regulates myelination. P0 and PMP22 myelin proteins are essential for an adequate structure of myelin sheath. Indeed, their disregulation or mutation is deleterious for myelin sheath structure, leading to peripheral neuropathies. P0 expression was drastically down-regulated in MPNST, and the knockout of the AHR enhanced P0 expression in Schwann cells. We showed that AHR predicted binding motifs in P0 and PMP22 promoters did not recruit AHR. We postulated that action of AHR is possibly mediated by β-Catenin because we observed an increase of β-Catenin binding on TCF/LEF binding sites of P0 and Pmp22 promoters after Ahr knock-down. We also showed that the KO of Ahr in mice activated Wnt signaling in SC.

AHR has a dual function in regulating gene expression as a ligand-activated transcription factor, and as an E3 ubiquitin ligase. Kawajiri et al., showed that AHR E3 ubiquitin activity has a role in β-Catenin degradation pathway that is independent of the APC system in intestine [START_REF] Kawajiri | Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands[END_REF]. We assume that the inhibition of AHR may reduce the degradation of β-Catenin, which is consistent with (i) the direct interaction that we have detected between AHR and β-Catenin proteins, and (ii) the β-Catenin increase observed after Ahr knock-down.

In conclusion, our findings unraveled that the AHR is involved in myelination process. This pathway is over-expressed in nerve tumors, which could also serve along with Wnt/β-Catenin pathway, as new markers for this specific type of cancer. As the inhibition of AHR induced apoptosis of MPNST cells, we can propose that this approach is further translatable. For instance, using either nanoparticles ( (38) 39) or Adeno Associated Virus (AAV) [START_REF] Luscan | The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis[END_REF] to deliver siAHR to induce apoptosis of these malignant cells could be suggested in adjuvant to existing chemotherapy with reduced doses. This approach can reduce the complications like chemotherapy-induced peripheral neuropathy (CIPN). So, our results indicate that AHR could represent a novel and a potential therapeutic target for this type of peripheral nerve sheath tumors that are poorly responsive to the existing chemotherapeutics.

MATERIALS AND METHODS

Animals

Ahr knock-out mice are a gift from Prof. Alvaro Puga (Cincinnati, USA). Ahr -/-mice and wild-type controls were maintained on a mixed strain background (C57BL/6j:RJ) and housed in a temperature-controlled room with a 12 hours light/dark cycle. All experiments were performed on age-matched male mice. Adults animals were fed ad libitum with water and Global-diet® 2016S from Harlan (Gannat, France). All aspects of animal care were approved by the Regional Ethic Committee (authorization CE2-04).

Treadmill test: forced locomotion

Adult males Ahr -/-(n=5) and control mice were acclimated to the testing room during 24 hours before each test. The forced locomotion of the mice was investigated using a commercial motorized treadmill. The speed of the treadmill was controlled by a tachymeter.

After habituation session (speed = 6cm/s), mice were tested at a speed of 10 cm/s and 16cm/s the next day.

Rod test-Static paradigm

The same set of animals was subjected to both the treadmill test and rod test. The set up consisted of a rod of 9.5 mm diameter and 5 cm length. After a period of habituation, animals were securely placed on the rod. The ability of the animal to remain on the rod without falling was investigated for a maximum period of 100 seconds.

Rod test-Dynamic paradigm

Dark platform were setup at one end of the rod, where the mice were let for habituation for 10 minutes. Mice were primed to walk from a start point along a bar (70 cm long, 9.5 mm diameter) fixed 30 cm above the bench. Once the mice had succeeded in reaching the final destination several times by priming procedure, the test was recorded in three trials. We calculated the speed, and the number of faults.

Rotarod Test: forced paradigm

Balance and motor coordination was tested using a motorized rotarod LE8200 apparatus (Bioseb, France). Adult were placed mice on a rotating treadmill drum (3 cm diameter) and mice's latency to fall during the first 5 minutes of the trial was noted. The average time of fall for each trial was measured. Fixed speed Rotarod at 14 rpm for five consecutive days for WT mice has been performed Ahr -/-mice (n=5).

Transmission electron microscopy

Electron microscopy was done using fixed sciatic nerves following the protocol described previously [START_REF] Makoukji | Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols[END_REF]. Electron microscopy images were used for calculating the g-ratio by ImageJ.

Patients and Samples

After clinical examination, the surgical removal of dermal neurofibromas was proposed in case of esthetical burden. Resection or removal of plexiform neurofibromas was described previously [START_REF] Luscan | The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis[END_REF].

Expression of genes involved in the AhR signaling pathway in patients' samples

RT-qPCR has been carried out as described previously [START_REF] Luscan | The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis[END_REF].

Immunohistochemistry

Human samples

Immunohistochemistry of patient samples has been carried out as described previously [START_REF] Massaad | A natural sequence consisting of overlapping glucocorticoid-responsive elements mediates glucocorticoid, but not androgen, regulation of gene expression[END_REF].

Immunostaining of AHR (rabbit polyclonal antibody clone H211, Santa Cruz) was done at 3 µg/ml after heat antigen retrieval in pH 6.0 citrate buffer. In all samples, we checked the absence of staining in intra-tumoral vessels and fibroblasts as internal negative controls.

Mouse samples

Sciatic nerves were dissected and immersed in 4% paraformaldehyde and embedded in OCT Sections (10 µm) were cut using Cryostat. P0 (Aves labs inc.) antibody, AHR antibody (Enzo). Then the samples were incubated at room temperature for 1h30 with the appropriate secondary antibody (Alexa Fluor 488 donkey anti-mouse, Cy3-conjugated AffiniPure Donkey anti-Rabbit and Cy3-conjugated Affinity Pure Donkey anti-Chicken). Nuclei were stained with Hoechst 33342 (Pierce Biotechnology). Sections were imaged using a confocal microscope (LSM510; Carl Zeiss).

Cell culture

The mouse SC line (MSC80) was maintained in Dulbecco's minimal essential medium (DMEM) supplemented with 10% decomplemented fetal calf serum (Hyclone-Perbio), 1% penicillin, 1% streptomycin (Gibco) and 1% Glutamine. All cultures were grown at 37°C in a humidified atmosphere of 5% CO2.

The MPNST-derived cell lines STS26T and 90-8 were maintained in advanced RPMI-1640 with 15% heat-inactivated FBS, 2.75‰ Bovine Pituitary Extract, 100U/ml penicillin, and 100μg/ml streptomycin (Invitrogen).

Plasmids and chemicals

p1646 (Cyp1A1-luc) was graciously provided by Dr A. Puga (Cincinnati, USA). siRNAs directed against Ahr were purchased from Qiagen (Lafayette, CO). The Ahr was targeted by four siRNAs recognizing four different regions of Ahr transcript. TCDD was purchased from

LGC standards, CH-22319 and 6, 2′, 4′-trimethoxyflavone (TMF) from Sigma.

Transient transfections

MSC80 cells (2.5 x 10 5 cells/well) were grown in 6-well plates, transfected using Effecten reagents according to manufactures instructions (Qiagen) and luciferase activity was determined using the enzymatic method described previously [START_REF] Frank | Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation[END_REF]. The b-galactosidase activity was used to normalize the transfection efficiency.

STS26T or 90-8 cells were transfected with either Non-Targetting siRNA (DHARMACON) or siAHR (DHARMACON) using RNAiMAX (Thermo fisher) according to the manufacturer's instruction.

Western Blot

WB assay was performed using standard techniques. Primary antibodies against P0 (and PMP22 were purchased from Abcam and Sigma respectively, β-Catenin from BD Transduction, Active β-Catenin from Millipore, α-tubulin) from Sigma, SOX2 from Abcam, and AHR from Enzo life science (Biomol SA-210).

qPCR for MSC80

Total RNA from cultured MSC80 was extracted using TRIzol® Reagent (Invitrogen, France) according to manufacturer's instruction. qPCR was done as described previously [START_REF] Makoukji | Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols[END_REF]. All results were normalized to the 26S mRNA level and calculated using the ΔCt method. The primer sequences used in real time qPCR are listed in the primers table.

Chromatin Immunoprecipitation

MSC80 cells (10 7 ) fixed with 1% formaldehyde for 10 min. The cross linking was quenched with 0.125M glycine for 10 minutes. Fixed chromatin was then isolated and physically sheared by sonication to obtain DNA fragments of length of 300-600 base pairs. Immunoprecipitation is done using Protein A/G magnetic nanobeads (Dynabeads life technologies). The antibodies used in ChIP assays are: 5 µg of AHR-specific antibody (Biomol SA-210) 5 µg of β-Catenin (BD transduction # 610154), Histone H3 (Signaling #2650), 5 µg Rabbit IgG (Sigma I5006). RT-qPCRs were done as mentioned earlier with the primer pairs listed in primers' table. Then the percentage of input has been calculated as mentioned in (43).

Co-Immunoprecipitation

MSC80 cell lysates were pre-cleared with protein-A (Dynabeads® life technologies) and then the total protein was measured with BioRad RCDC. The lysate has been treated with DNAse to digest the genomic DNA. 3 µg of AHR antibody (BD transduction) is used to enrich AHR in 100 μg of total protein by using protein A Dynabeads (Rabbit IgG is used as negative control). Finally, the enriched protein samples were blotted with usual standard WB techniques with β-Catenin antibody (Biomol SA-210).

Flow cytometry analysis

STS26T or 90-8 cells cultured in 12-well plates were treated with AHR antagonists or DMSO. Cells undergoing apoptosis at the indicated time were identified using Annexin V-FITC apoptosis detection kit (Abcam ab14085), following the manufacturer's instruction.

BD FACSCanto™II was used. A total of 10000 events were recorded at a light scatter to exclude debris and aggregate with a flow rate of less than 200 cells/second for each assay.

The compensations and the settings were adjusted according to the assay. Data were analyzed using FlowJo Software.

Statistical analysis

Unless otherwise specified, means of treatment groups were compared with one-way analysis of variance (ANOVA). When the ANOVA showed that there were significant differences between the groups, Tukey's test was used to identify the sources of these differences. A p value of ≤ 0.05 was considered statistically significant. Two groups comparisons were performed by the Student test. As the mRNA levels did not fit a Gaussian distribution in human samples, (a) the mRNA levels in each subgroup of samples were expressed as their median values and ranges, rather than their mean values and coefficients of variation, and (b) comparison between the three types of nerve sheath tumors were assessed by using the non-parametric Kruskal Wallis H test. Differences were considered significant at confidence levels greater than 95% (p < 0.05). The average speed to cross the rod was measured (cm/s). I, The number of faults (slips) counted for either WT or Ahr -/-. At least 5 animals per group were tested. *p<0.05, **p<0.01, ***p<0.001 by Student's t test when Ahr -/-were compared to WT mice. J, Sciatic nerves were isolated from either WT or Ahr -/-mice (8-weeks old). Then, ultrathin (50 -90 nm) crosssections were prepared from Epon embedded nerves. Scale bar, 2µm. K, Myelin thickness was calculated by g-ratio determination and L, axonal perimeter was estimated using electronic microscopy pictures quantified by ImageJ software. At least five animals per genotype were used. M, g-ratios were plotted against axonal perimeter. N, Adult male WT or Ahr -/-mice were sacrificed, and then their sciatic nerves were dissected (at least n=6 per group). Total proteins were extracted, and western blots were performed using antibodies against P0, PMP22, SOX2, KROX20, β-Catenin, Active β-Catenin and α-tubulin (loading control). Figures represent a typical

ACKOWLEDGEMENTS:

Figure S5: Uncropped western blots images of blots shown in main figures.

active β-catenin to total β-catenin is increased 3.5-fold in Ahr -/- mice, suggesting an activation of the Wnt/β-catenin pathway.

Ahr Is Involved in Myelination During Development. To determine when these myelin abnormalities arose, we analyzed the expression pattern of AHR during the myelination process at P7, P21, and in 8-wk-old (8WO) mice and compared it to the expression of positive modulators of the myelination process: KROX20 and β-catenin. As depicted in Fig. 4A, AHR expression was at the highest level at P7 and then decreased at later time points to reach its lowest level in adult mice. KROX20 expres-sion gradually increased during the myelination process to attain the highest level at P21 and, as expected, dropped in adult animals. Finally, β-catenin increased at P21, and then its expression was brought back to the same levels of P7 and at 8WO.

Taking account of this difference in AHR expression during development, we analyzed the structure of myelin sheaths from sciatic nerves of P7 mice (Fig. 4B). We observed a mild disorganization of myelin sheaths in Ahr -/-mice without affecting the g ratio (Fig. 4C). A moderate increase of the axonal perimeter was detected in Ahr -/-mice (Fig. 4D). Nevertheless, Ahr -/-mice displayed fewer myelinated axons (28.88 ± 1.18 for WT vs. 20.88 ± 1.23 for Ahr -/-; Fig. 4E). P0 (-50%) and PMP22 (-60%) protein expression was decreased in 7-d-old Ahr -/-mice (Fig. 4F). To explore if myelin gene inhibition is due to a dysregulation in the expression of the major transcriptional regulators of SC myelination, we quantified the expression of SOX2, KROX20, total β-catenin, and active β-catenin. The knockout of Ahr did not affect the expression of SOX2. However, we observed a decreased KROX20 expression (-60%) that was confirmed by immunohistochemistry experiments. We observed a 25% reduction in the number of KROX20-positive cells in the sciatic nerves as suggested by DAPI (Fig. 4G). Furthermore, WB analyses showed that active β-catenin expression was diminished Cyp1A1 promoter. As expected, the AHR bound to the Cyp1A1 promoter (Fig. 5D). This binding was enhanced by twofold after treatment with TCDD (100 nM, 1 h). However, we did not detect AHR interaction with any of the putative binding sites identified on Pmp22 (Fig. 5E) and P0 (Fig. 5F), even after the incubation of MSC80 with TCDD (loading control, Fig. S4A). These data showed that AHR does not seem to interact directly with myelin gene promoters.

The other possible mechanism of action of AHR is the crosstalk with another signaling pathway. We previously showed that the activated Wnt/β-catenin pathway enhances the expression of peripheral myelin genes [START_REF] Tawk | Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis[END_REF]. Furthermore, we demonstrated that the knocking out of Ahr in mice altered β-catenin expression in the sciatic nerve (Fig. 3N). Therefore, we addressed the question of whether the action of AHR is mediated by the Wnt/β-catenin pathway. After silencing Ahr in MSC80 cells, we observed a 50% increase in the protein levels of active β-catenin and a 30% increase of total β-catenin levels (Fig. 5G). Furthermore, to support the hypothesis, knockdown of Ahr led to a significant stimulation of mRNA expression levels of Wnt signaling components Lrp6, Dvl2, Dvl3, and Axin2 (Fig. 5H). Then, we assayed the functionality of the Wnt/β-catenin pathway. The SuperTOP Flash-Luciferase construct, bearing several binding sites for T cell factor/lymphoid enhancer factor (TCF/LEF), was activated by 2.5-fold 48 h after siAHR (Fig. 5I). To assess how AHR modifies β-catenin levels in MSC80 cells, we assumed that AHR is able to interact with β-catenin and stimulate its degradation as described in intestine cancer cells [START_REF] Kawajiri | Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands[END_REF]. Immunoprecipitation of AHR indicated proteinprotein interaction of β-catenin and AHR in MSC80 cells (Fig. 5J).

Consequently, we hypothesized that the knockdown of Ahr increases the recruitment of β-catenin with TCF/LEF complex on the level of myelin gene promoters. We localized LEF/TCFβ-catenin binding sites on P0 and PMP22 promoters (12) (Fig. 5K). ChIP assays with β-catenin antibodies showed that Ahr silencing increased the recruitment of β-catenin on P0 (Fig. 5L and Fig. S4B, loading control) and Pmp22 promoters (Fig. 5M and Fig. S4B). Moreover, the binding of β-catenin was also enhanced after Ahr silencing on the level of a Wnt target gene, Axin2 (Fig. S4C). GAPDH was used as a negative control (Fig. S4D). Collectively, these data demonstrate that AHR exerts its effect on myelin genes through the Wnt/β-catenin pathway.

Discussion

We reveal that AHR plays a crucial role in the myelination process of the nerve and is overexpressed in nerve tumors. We demonstrated that the AHR signaling pathway is activated in a series of NF1-associated nerve sheath tumors. We further analyzed other genes linked to the AHR and involved in tryptophan metabolism that lead to the synthesis of kynurenine, an endogenous ligand of AHR [START_REF] Kawajiri | Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands[END_REF][START_REF] Mezrich | An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells[END_REF][START_REF] Zhai | The role of IDO in brain tumor immunotherapy[END_REF]. The expression of two genes participating in the first steps of tryptophan metabolism, namely IDO1 and TDO2, was significantly increased in PNFs and MPNSTs. IDO1 and TDO2 were found to be remarkably increased in malignant form compared with the benign form of these tumors, suggesting an increased AHR activity in the malignant transformation. The enzyme IDO1 mediates the first, rate-limiting, step in tryptophan metabolites to kynurenine and is up-regulated under an inflammatory microenvironment [START_REF] Litzenburger | Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR[END_REF]. Through generation of downstream metabolites, IDO1 enzyme activity may affect immunity, including specific immunomodulatory or cytotoxic functions [START_REF] Mezrich | An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells[END_REF]. It has been reported that L-kynurenine activates AHR [START_REF] Opitz | of the human aryl hydrocarbon receptor[END_REF], which positively regulates IDO1 expression in immune cells, such as dendritic cells. Our observation showing a progressive up-regulation of IDO1 and TDO2 in PNFs (threefold and fivefold) and a further stimulation in MPNSTs (50fold and 25-fold) suggests that kynurenine synthesis leading to AHR activation may play a role in peripheral nerve sheath tumor progression to malignancy.

In addition to the biallelic inactivation of the NF1 gene, supplemental genetic lesions are necessary for malignant progression of PNFs. Alterations of additional genes (CDKN2A/B, TP53, SUZ12, EED) were detected in MPNSTs [START_REF] Tucker | Association between benign and malignant peripheral nerve sheath tumors in NF1[END_REF][START_REF] Zhu | Neurofibromas in NF1: Schwann cell origin and role of tumor environment[END_REF]. We have previously shown that the Wnt/β-catenin pathway was dysregulated in MPNSTs [START_REF] Quintana | Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor[END_REF], and the present study reveals that the AHR pathway is also activated in these tumors. Furthermore, we have described an elevation of Wnt5a [START_REF] Quintana | Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor[END_REF] and AHR expression in MPNST tumors. Conversely, the knockdown of AHR in MPNST cells inhibits Wnt5a expression (Fig. S2 H andI). Therefore, our data suggest a possible link between AHR and Wnt/β-catenin pathways in MPNSTs.

Consequently, we inhibited AHR in MPNST cell lines to alter their survival. Both AHR antagonists (CH or TMF) and siAHR induced apoptosis of two MPNST cell lines: 90-8 and STS26T. Again, this observation highlights the importance of AHR in SC malignancy in addition to NF1. Furthermore, AHR inhibition could down-regulate IL-1β, which was elevated in MPNST tumors. Previous results suggested that AHR activation coupled with inflammatory signals can lead to synergistic induction of IL-6 expression in tumor cells [START_REF] Luscan | The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis[END_REF]. We revealed a significant increase of IL-1β, IL-6, IL-8, CXCL5, and CXCL6 mRNA levels in PNFs and MPNSTs. These results confirm previous in vitro findings showing that AHR activation may promote the induction of IL-6 and IL-8 [START_REF] Dinatale | Mechanistic insights into the events that lead to synergistic induction of interleukin 6 transcription upon activation of the aryl hydrocarbon receptor and inflammatory signaling[END_REF][START_REF] Kolasa | AhR-and NF-κB-dependent induction of interleukin-6 by co-exposure to the environmental contaminant benzanthracene and the cytokine tumor necrosis factor-α in human mammary MCF-7 cells[END_REF] and highlight the implication of AHR in the regulation of an inflammation pathway [START_REF] Vogel | Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-κB[END_REF].

Previous studies from our laboratories and others have shown that some signaling pathways that are involved in the myelination process (Wnt/β-catenin, mTOR, ERK) are deregulated in MPNST [START_REF] Tawk | Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis[END_REF][START_REF] Hollingshead | Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells[END_REF][START_REF] Murray | Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity[END_REF]. Therefore, we inquired about the endogenous role of AHR in normal SC physiology and peripheral nerve myelination. We revealed that AHR is expressed in SC and in the sciatic nerve and that Ahr -/-mice present an alteration in locomotion. Additionally, electron microscopy analyses depicted thinner myelin sheaths. These data unveil the role of AHR on SC myelinating functions. We performed electron microscopy analyses during the myelination process. They depicted a disorganization of myelin sheaths depending on the developmental stage. The first observation was that the myelin thickness was not affected at an early stage of myelination (P7). However, the number of myelinated axons was decreased in Ahr -/-mice, suggesting a delay in myelination. Then, we observed thicker myelin sheaths at P21, while adult animals had thinner myelin sheaths around the axons. These observations could be comparable to CMT1A patients (duplication of the PMP22 gene) who AHR is predominantly expressed in SCs compared with mast cells and endothelial cells. Total RNA was isolated from normal human tissues. The gene mRNA levels (calculated as described in Materials and Methods) were based on the amount of the target message relative to the endogenous control TBP message, to normalize the starting amount and quality of total RNA. NE, not expressed. active β-catenin to total β-catenin is increased 3.5-fold in Ahr -/- mice, suggesting an activation of the Wnt/β-catenin pathway.

Shackleford

Ahr Is Involved in Myelination During Development. To determine when these myelin abnormalities arose, we analyzed the expression pattern of AHR during the myelination process at P7, P21, and in 8-wk-old (8WO) mice and compared it to the expression of positive modulators of the myelination process: KROX20 and β-catenin. As depicted in Fig. 4A, AHR expression was at the highest level at P7 and then decreased at later time points to reach its lowest level in adult mice. KROX20 expres-sion gradually increased during the myelination process to attain the highest level at P21 and, as expected, dropped in adult animals. Finally, β-catenin increased at P21, and then its expression was brought back to the same levels of P7 and at 8WO. Taking account of this difference in AHR expression during development, we analyzed the structure of myelin sheaths from sciatic nerves of P7 mice (Fig. 4B). We observed a mild disorganization of myelin sheaths in Ahr -/-mice without affecting the g ratio (Fig. 4C). A moderate increase of the axonal perimeter was detected in Ahr -/-mice (Fig. 4D). Nevertheless, Ahr -/-mice displayed fewer myelinated axons (28.88 ± 1.18 for WT vs. 20.88 ± 1.23 for Ahr -/-; Fig. 4E). P0 (-50%) and PMP22 (-60%) protein expression was decreased in 7-d-old Ahr -/-mice (Fig. 4F). To explore if myelin gene inhibition is due to a dysregulation in the expression of the major transcriptional regulators of SC myelination, we quantified the expression of SOX2, KROX20, total β-catenin, and active β-catenin. The knockout of Ahr did not affect the expression of SOX2. However, we observed a decreased KROX20 expression (-60%) that was confirmed by immunohistochemistry experiments. We observed a 25% reduction in the number of KROX20-positive cells in the sciatic nerves as suggested by DAPI (Fig. 4G). Furthermore, WB analyses showed that active β-catenin expression was diminished by 30% in Ahr -/-nerves (Fig. 4F). As the amount of total β-catenin was increased in Ahr -/-mice (+35%), we observed a decrease in the ratio of active β-catenin to total β-catenin, suggesting an impairment of the Wnt/β-catenin pathway at P7 when Ahr is knocked out. At P21, electron microscopy images revealed that myelin sheaths are affected by the deletion of Ahr (Fig. 4H). The g ratio was decreased, designating thicker myelin sheaths around the axons of Ahr -/-mice (Fig. 4I). The axonal perimeter was reduced (Fig. 4J) while the numbers of myelinated were not affected in Ahr -/-mice (Fig. 4K). At P21, P0 and PMP22 expression were stimulated by twofold in Ahr -/-mice. SOX2 expression was still not affected, while the expression of all of the positive regulators was activated in Ahr -/- mice: KROX20 (+50%), total β-catenin (+60%), and active β-catenin (+35%) (Fig. 4L). Altogether, our data point out a crucial and differential role of Ahr during the myelination process and highlight that Ahr knockout leads to defects in myelin sheaths.

AHR Regulates Myelin Gene Expression in SCs. We transfected MSC80 cells with either nontargeting siRNA (NT) or siAhr. First, the efficacy of the knockdown was evaluated by qRT-PCR (Fig. S3A) and WB (Fig. S3B). In addition, we assessed the functional efficacy of the siAhr on Cyp1A1-luciferase activity that was reduced drastically (-80%) (Fig. S3C). The knockdown of Ahr increased mRNA levels of P0 and Pmp22 by 50% (Fig. 5A) and the promoter activity of P0 and Pmp22 (Fig. 5B). Taken together, the silencing of Ahr in the SC line or its knockout in mice led to a dysregulation of myelin gene expression.

Then, we examined the mechanism by which the AHR regulates myelin gene expression. We identified by MatInspector software four potential binding sites for AHR on the level of P0 promoter and one putative AHR binding site on the Pmp22 promoter (Fig. 5C). Therefore, we tested the AHR binding on P0 and Pmp22 promoters by ChIP. As a positive control, we assayed the binding of the AHR on the level of its target gene, are hypermyelinated in early childhood and then, 1 y after, a hypomyelination of some fibers is observed; it is caused by demyelination and remyelination cycles [START_REF] Azim | GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo[END_REF]. The Ahr constitutive invalidation also modified the perimeters of the axons, showing a correlation between the formation of the myelin sheaths and axonal development. However, we cannot exclude that could also affect neuronal development directly. Prenatal exposure of TCDD in rats provoked a delay in oligodendrocyte differentiation and maturation [START_REF] Kendall | CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin[END_REF]. TCDD could also disrupt the functions of AHR to provoke neuropathies. In fact, rats intoxicated by TCDD showed severe defects in myelin structure of tibial and sciatic nerve and reduction in nerve conduction velocity [START_REF] Brundage | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1[END_REF][START_REF] Fernández | A single prenatal exposure to the endocrine disruptor 2,3,7,8-tetrachlorodibenzo-p-dioxin alters developmental myelination and remyelination potential in the rat brain[END_REF]. Our results reinforce not only the endogenous role of AHR in a normal myelination process but also the mechanism by which it regulates myelination. P0 and PMP22 myelin proteins are essential for an adequate structure of myelin sheath. Indeed, their dysregulation or mutation is deleterious for myelin sheath structure, leading to peripheral neuropathies. P0 expression was drastically down-regulated in MPNST, and the knockout of AHR enhanced P0 expression in SCs. The knockout of Ahr severely altered P0 and PMP22 expression during myelin development. At P7, when AHR expression is supposed to reach its maximal expression, we observed an inhibition of P0 and PMP22 expression, while starting from P21 until adulthood the KO of Ahr increased the expression of myelin genes. Thus, it appears that AHR differentially regulates P0 and PMP22 during development. The dysregulation of the myelin gene could be attributed to a modification of developmental markers that modulate P0 and PMP22 expression. For example, at P7, the positive regulators of myelin gene expression (KROX20 and β-catenin) are down-regulated. This undoubtedly provoked the inhibition of P0 and PMP22. At later time points (P21 and adult), myelin genes are activated consequently to the Ahr ablation. Concomitantly, KROX20 and β-catenin are overexpressed and SOX2 (negative effector) is inhibited.

  This work was funded by INSERM, University Paris Descartes, the Agence National pour la Recherche (ANR) and the Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du travail (ANSES). GGS, NKS, MH, and AC received PhD fellowships from the French Ministry of Research (MNRT). LJ received a PhD fellowship from Region Ile de France. The authors greatly acknowledge Dr Alain Schmitt of the Cochin Imaging Facility, Jean-Maurice Petit of the Imaging Facility des Saints Pères and Stephanie Dupuy from the flow cytometry facility.

Figure legends

  Figure legends

Figure 1 :

 1 Figure 1: AHR nuclear staining is detected in MPNST tissues. Formalin fixed, paraffin embedded human MPNST samples were stained with Hematoxylin-eosin-saffron (HES) and AHR was revealed by a specific antibody. A strong nuclear AhR staining was detected in a proportion of tumor cells while intra-tumoral vessels (arrows) and fibroblasts in a fibrous septa (*) were not stained, taken as internal negative controls. Peroxidase technique, diaminobenzidine chromogen, haematoxylin counterstain. Scale bar 100 µm.

Figure 2 :

 2 Figure 2: AHR inhibition causes apoptosis in MPNST cell line. A-B, STS26T cells were treated with either AhR antagonists (CH-223191 or TMF) or DMSO (vehicle) during 48h (A) or 72h (B). Cells are stained with Annexin and PI to detect cell death by flow cytometry: living cell population (Annexin V -/PI -), apoptotic cells (Annexin V + /PI -), late apoptotic cells (Annexin V + /PI + ) and dead cells (Annexin V -/PI + ). Results represent the means +/-SEM of at least four independent experiments. *p<.05, **p<.01, by Bonferroni's post hoc tests after one-way ANOVA when compared to DMSO. C, STS26T cell line was treated with either AHR antagonists (CH-223191 or TMF) or DMSO (vehicle). 48h later, total RNA was extracted and RT-qPCR was performed using primers recognizing CYP1A1 and TBP to normalize the results. They represent the means +/-SEM of at least five independent experiments. *p<.05, ***p<0.001 by Student's t test when compared to DMSO. D, STS26T cells were transfected with either siAhR (10nM and 20nM) or NT; 72h after medium change,

Figure 3 :

 3 Figure 3: Ahr ablation modifies myelin structure and locomotor behavior in adult mice. A, Immunohistochemistry was performed on WT sciatic nerve to localize AhR (green) and P0 (red). The slides were imaged using confocal microscope. This experiment was repeated at least three times, and a typical experiment is presented here. Scale bar = 100 μm. B, Immunocytochemistry experiment was performed on MSC80 cells. AHR localization is highlighted in red; nuclei were stained with Hoechst (blue). This experiment was repeated at least three times, and a typical experiment is presented here. Scale bar = 10 μm. C, Western blot showing the expression of AhR in MSC80 cells and in sciatic nerve. D, Gait parameter: 8 weeks-old WT and Ahr -/-mice were placed on a treadmill at the speed of 10 cm/s and 16 cm/s. Stride time was measured. E, Rotarod test : 8 weeks-old WT and Ahr -/-mice were subjected to Rotarod test for five days. The time that mice could stay on the Rotarod was measured each day. At least 5 animals per group were tested. *p<0.05, ** p<0.01 Tukey's post hoc tests after one-way ANOVA when compared with control for each day of the experiment. F, Rod test: Eight weeks-old WT and Ahr -/-mice were placed on the rod to perform either static or dynamic rod tests. Representative pictures of the posture of the mice on the rod. The red arrowhead indicates right hind limb where Ahr -/-mouse slipped G, Static rod test: Measurement of the time that WT and Ahr -/-mice could stay without dropping from

  experiment. Western blots were quantified using ImageJ software. Black horizontal line between the lanes in the gels signifies a crop was made. Error bars indicate SEM *p<0.05, **p<0.01, ***p<0.001 by Student's t test when Ahr -/-were compared to control mice.

Figure 4 :

 4 Figure 4: The KO of Ahr alters myelin ultrastructure, myelin proteins and myelination regulators during development. A, sciatic nerves from P7, P21 and 8 weeks-old mice were extracted and total protein was prepared. AHR, KROX20, β-catenin expression levels were determined by WB. a tubulin served as loading control. Figures represent a typical

  experiment. Ultrathin (50 -90 nm) cross-sections were prepared from epon embedded P7, and P21 sciatic nerves. B, Electron micrographs of P7 mice (scale bar = 2µm) C, Myelin thickness of P7 mice sciatic nerves was estimated by g-ratio determination using electron microscopy pictures quantified by Image J software. D, Axonal perimeter was measured by Image J software. E, The number of myelinated axons were counted in a given unit area. F, P7 male WT or Ahr-/-mice were sacrificed, and then their sciatic nerves were dissected (at least n=6 per group). Total proteins were extracted, and western blots were performed using antibodies against P0, PMP22, Sox2, Krox20, β-Catenin, Active β-Catenin and α-tubulin (loading control). Figures represent a typical experiment. G, Immunohistochemistry was performed on WT or Ahr-/-sciatic nerves (P7). The slides were analyzed with a confocal microscope: Krox20 (red), P0 (green), DAPI (blue). This experiment was performed with at least 4 animals per each group, and a typical experiment was presented here. Scale bars = 50 μm. The number of Krox20 positive cells and DAPI positive cells was counted by means of ImageJ. **p<0.01, by Student's t-test compared to control (WT). H, Electron micrographs of P21 mice (sale bare = 2µm), I, g-ratio determination using electron microscopy pictures quantified by ImageJ software. J, Axonal perimeter was measured. K, The number of myelinated axons were counted in a given unit area. Error bars indicate SEM. ***p<0.001, by Student's t test when Ahr-/-were compared to WT mice. L, P21 male WT or Ahr-/-mice were sacrificed, and then their sciatic nerves were dissected (at least n=6 per group). Total proteins were extracted, and western blots were performed using antibodies against P0, PMP22, Sox2, Krox20, β-Catenin, Active β-Catenin and α-tubulin.Figures represent a typical experiment. Western blots were quantified using ImageJ. Error bars indicate SEM *p<0.05, **p<.001, ***p<0.001, by Student's t test when Ahr-/-were compared to WT mice.

Figure 5 :

 5 Figure 5: AHR does not bind to myelin gene promoters in MSC80 cells but acts via Wnt/β-Catenin pathway. MSC80 cells were transfected with a siRNA directed against Ahr (siAhr) or a non-targeting siRNA (NT). A, Total mRNA was extracted and P0 and Pmp22 transcripts were quantified by RT-qPCR. All results were normalized to the 26S mRNA level. B, MSC80 cells were co-transfected with siAhr or NT and P0-luciferase or PMP22-luciferase constructs. Luciferase activity was assayed. Results represent the means +/-SEM of at least five independent experiments. *p<.05, ***p<0.001 by Student's t test when compared with control (NT). C. Putative binding sites of AHR located on the levels of P0 and PMP22 were identified by means of MatInspector software. MSC80 cells were incubated with vehicle (Nonane) or TCDD (100nM, 24h). Chromatin immunoprecipitation assays with antibodies against AHR or Mock IgG (non-relevant negative control) or Histone H3 (positive control) have been done. RT-qPCR was performed with primers recognizing AHR putative sites located on D, Cyp1A1 an AHR target gene; E, Pmp22; F, P0 genes. Results represent the means +/-SEM of at least four independent experiments. *p<.05, **p<.01, ***p<0.001 by Tukey's post hoc tests after one-way ANOVA when compared with control. MSC80 cells were transfected with siRNA directed against Ahr (siAhr) or a non-targeting siRNA (NT) for 48h. Proteins were extracted, and Western blots were performed using antibodies against G,

Figure S1 :

 S1 Figure S1: Representative dot plots of flow cytometry quantification. A, STS26T cells were treated either with AHR antagonists (CH (50µM) and TMF (10µM)) or Vehicle (DMSO) during 48h or 72h. Percentage of apoptotic cells (Annexin V + /PI -), dead cells (Annexin V - /PI + ), late apoptotic cells (Annexin V + /PI + ) and living cells (Annexin V -/PI -) was analyzed by flow cytometry. Human MPNST cell line (STS26T) was reverse transfected with either siAHR or NT. B, Representative dot plots of STS26T cells silenced with siAHR.

Figure S2 :

 S2 Figure S2: AHR inhibition causes apoptosis in MPNST cell line A, 90-8 cells were treated with either CH-223191 (50µM, 48h) or DMSO (vehicle). Total RNA was extracted and RT-qPCR experiments were performed using primers recognizing CYP1A1 and CYP1B1. Results were normalized to the TBP mRNA level. They represent the means +/-SEM of at least five independent experiments. B-C 90.8 cells were treated with either CH-223191 (50µM, 48h or 72h) or DMSO (vehicle). 48h or 72 after treatment, cells are stained with Annexin and PI to detect cell death by flow cytometry: living cell population (Annexin V -

Figure S3 :

 S3 Figure S3: Silencing efficiency of siAhr. MSC80 cells were transfected with non-targeting siRNA or a siRNA against Ahr (siAhr). A, Total RNA was extracted, and quantitative realtime PCR experiments were performed using primers recognizing Ahr. The RT-PCR was normalized using 26S RNA. Results represent the mean +/-SEM of at least eight independent experiments. B, Proteins were extracted and Western blots were performed using antibodies against AHR and α-tubulin (normalization of the Western blots). Figures represent a typical

  experiment. Western blots quantification was done using Image J software. The data represent the mean+/-SEM of at least 4 independent experiments. C, MSC80 cells were transiently transfected CYP1A1-luc construct and with either siAhr or NT. 48h later, luciferase activity was analyzed. Results represent the means +/-SEM of at least 6 independent experiments performed in duplicate. ***p<0.001 by Student's t test compared to control (NT).

Figure S4 :

 S4 Figure S4: Controls for ChIP assays. A, Western blot for ChIP assay where AHR antibody was used to precipitate AHR bound DNAs. MSC80 cells were treated with Nonane (vehicle)

Figure 1 .

 1 Figure 1.

  et al. PNAS | Published online January 19, 2018 | E1323

Fig. 1 .

 1 Fig. 1. (A and A′) AHR nuclear staining is detected in MPNST tissues. Formalin-fixed, paraffin-embedded human MPNST samples were stained with hematoxylin-eosin-saffron (HES), and AHR was revealed by a specific antibody. (A) A strong nuclear AHR staining was detected in a proportion of tumor cells, while intratumoral vessels (arrows) and fibroblasts in a fibrous septa (*) were not stained, taken as internal negative controls. (A′) A peroxidase technique, diaminobenzidine chromogen, and hematoxylin counterstain were employed. (Scale bar, 100 μm.)

Figure 2 .

 2 Figure 2.

Fig. 2 .

 2 Fig. 2. AHR inhibition causes apoptosis in the MPNST cell line. (A and B) STS26T cells were treated with either AHR antagonists (CH or TMF) or DMSO (vehicle) for 48 h (A) or 72 h (B). Cells are stained with Annexin and PI to detect cell death by flow cytometry: living cell population (Annexin V -/PI -), apoptotic cells (Annexin V + /PI -), late apoptotic cells (Annexin V + /PI + ), and dead cells (Annexin V -/PI + ). Results represent the means ± SEM of at least four independent experiments. *P < 0.05, **P < 0.01, by Bonferroni's post hoc tests after one-way ANOVA compared with DMSO. (C) The STS26T cell line was treated with either AHR antagonists (CH or TMF) or DMSO (vehicle). Forty-eight hours later, total RNA was extracted and qRT-PCR was performed using primers recognizing CYP1A1 and TBP to normalize the results. They represent the means ± SEM of at least five independent experiments. *P < 0.05 by Student's t test compared with DMSO. (D) STS26T cells were transfected with either siAHR (10 nM and 20 nM) or NT; 72 h after medium change, cells were stained with Annexin and PI to detect cell death by flow cytometry: living cell population (Annexin V -/PI -), apoptotic cells (Annexin V + /PI -), late apoptotic cells (Annexin V + /PI + ), and dead cells (Annexin V -/PI + ). Results represent the means ± SEM of at least four independent experiments. *P < 0.05 by Bonferroni's post hoc tests after one-way ANOVA compared with control (NT). (E) STS26T cells were transfected with siAHR (20 nM) or NT; 72 h later, total RNA was extracted and qRT-PCR was performed using primers to amplify AHR, CYP1A1, and CYP1B1. Results were normalized to the TBP mRNA level and represent the means ± SEM of at least five independent experiments. *P < 0.05 by Student's t test compared with control (NT). (F) STS26T cells were reverse-transfected with siAHR (20 nM) or NT or incubated with CH (50 μM, 72 h), TMF (10 μM, 72 h), or DMSO. Total RNA was extracted and qRT-PCR experiments were performed using primers recognizing IL-1β and TBP to normalize. Results represent the means ± SEM of at least five independent experiments. *P < 0.05 by Student's t test compared with control (NT).

Figure 3 .

 3 Figure 3.

Fig. 3 .

 3 Fig.3. Ahr ablation modifies myelin structure and locomotor behavior in adult mice. (A) Immunohistochemistry was performed on WT sciatic nerve to localize AHR (green) and P0 (red). The slides were imaged using a confocal microscope. This experiment was repeated at least three times, and a typical experiment is presented here. (Scale bar, 100 μm.) (B) An immunocytochemistry experiment was performed on MSC80 cells. AHR localization is highlighted in red; nuclei were stained with Hoechst (blue). This experiment was repeated at least three times, and a typical experiment is presented here. (Scale bar, 10 μm.) (C) WB showing the expression of AHR in MSC80 cells and in sciatic nerve. (D) In the gait parameter, 8-wk-old WT and Ahr -/-mice were placed on a treadmill at the speed of 10 cm/s and 16 cm/s. Stride time was measured, ***P < 0.001 by Student's t test when Ahr -/-were compared with control mice. (E) For the rotarod test, 8-wk-old WT and Ahr -/-mice were subjected to the rotarod test for 5 d. The time that mice could stay on the rotarod was measured each day. At least five animals per group were tested. *P < 0.05, **P < 0.01 using Mann-Whitney test compared with control for each day of the experiment. (F) For the rod test, 8-wk-old WT and Ahr -/-mice were placed on the rod to perform either static or dynamic rod tests. Representative pictures of posture of the mice on the rod are shown. The arrowhead indicates right hind limb where the Ahr -/-mouse slipped (G) For the static rod test, measurement of the time that WT and Ahr -/-mice could stay without dropping from the rod. The test was stopped when mice succeeded in staying 100 s. (H) For the dynamic rod test, the average speed to cross the rod was measured (cm/s). (I) The number of faults (slips) counted for either WT or Ahr -/-. At least five animals per group were tested. *P < 0.05, **P < 0.01 by Student's t test when Ahr -/-were compared with WT mice. (J) Sciatic nerves were isolated from either WT or Ahr -/-mice (8 wk old). Then, ultrathin (50-90 nm) cross-sections were prepared from Epon embedded nerves. (Scale bar, 2 μm.) (K) Myelin thickness was calculated by g-ratio determination. (L) Axonal perimeter was estimated using electronic microscopy pictures quantified by ImageJ software. At least five animals per genotype were used. (M) The g ratios were plotted against the axonal perimeter. (N) Adult male WT or Ahr -/-mice were killed, and then their sciatic nerves were dissected (at least n = 6 per group). Total proteins were extracted, and WBs were performed using antibodies against P0, PMP22, SOX2, KROX20, β-catenin, active β-catenin, and α-tubulin (loading control). Figures represent a typical experiment. WBs were quantified using ImageJ software. Black horizontal line between the lanes in the gels signifies a crop was made.Error bars indicate SEM. *P < 0.05, **P < 0.01 by Student's t test when Ahr -/-were compared with control mice.

Figure 4 .

 4 Figure 4.

Fig. 4 .

 4 Fig. 4. The KO of Ahr alters myelin ultrastructure, myelin proteins, and myelination regulators during development. (A) Sciatic nerves from at least 4 mice of age P7 and P21 were extracted and total protein was prepared. AHR, KROX20, and β-catenin expression levels were determined by WB. α-tubulin served as the loading control. Figures represent a typical experiment. Ultrathin (50-90 nm) cross-sections were prepared from epon embedded P7, and P21 sciatic nerves. (B) Electron micrographs of P7 mice. (Scale bar, 2 μm.) (C) Myelin thickness of P7 mice sciatic nerves was estimated by g-ratio determination using electron microscopy pictures quantified by Image J software. (D) Axonal perimeter was measured by ImageJ software. (E) The number of myelinated axons were counted in a given unit area. (F) P7 male WT or Ahr -/-mice were killed, and then their sciatic nerves were dissected (at least n = 6 per group). Total proteins were extracted, and WBs were performed using antibodies against P0, PMP22, SOX2, KROX20, β-catenin, active β-catenin, and α-tubulin (loading control). Figures represent a typical experiment. (G) Immunohistochemistry was performed on WT or Ahr -/-sciatic nerves (P7). The slides were analyzed with a confocal microscope: KROX20 (red), P0 (green), and DAPI (blue). This experiment was performed with at least four animals per each group, and a typical experiment was presented here. (Scale bars, 50 μm.) The number of KROX20-positive cells and DAPI-positive cells was counted by means of ImageJ. (H) Electron micrographs of P21 mice. (Scale bar, 2 μm.) (I) The g-ratio determination using electron microscopy pictures quantified by ImageJ software. (J) Axonal perimeter was measured. (K) The number of myelinated axons were counted in a given unit area. Error bars indicate SEM. (L) P21 male WT or Ahr -/-mice were killed, and then their sciatic nerves were dissected (at least n = 6 per group). Total proteins were extracted, and WBs were performed using antibodies against P0, PMP22, SOX2, KROX20, β-catenin, active β-catenin, and α-tubulin. Figures represent a typical experiment. WBs were quantified using ImageJ. Error bars indicate SEM. *P < 0.05, **P < 0.01, ***P < 0.001, by Student's t test when Ahr -/-were compared with WT mice.

Fig. 5 .

 5 Fig. 5. AHR does not bind to myelin gene promoters in MSC80 cells but acts via the Wnt/β-catenin pathway. MSC80 cells were transfected with a siRNA directed against Ahr (siAHR) or a NT siRNA (NT). (A) Total mRNA was extracted, and P0 and Pmp22 transcripts were quantified by qRT-PCR. All results were normalized to the 26S mRNA level. (B) MSC80 cells were cotransfected with siAhR or NT and P0-luciferase or PMP22-luciferase constructs. Luciferase activity was assayed. Results represent the means ± SEM of at least five independent experiments. ***P < 0.001 by Student's t test compared with control (NT). (C) Putative binding sites of AHR located on the levels of P0 and PMP22 were identified by means of MatInspector software. MSC80 cells were incubated with vehicle (Nonane) or TCDD (100 μM, 24 h). ChIP assays with antibodies against AHR or Mock IgG (nonrelevant negative control) or Histone H3 (positive control) were performed. qRT-PCR was performed with primers recognizing AHR putative sites located on (D) Cyp1A1, an AHR target gene; (E) Pmp22; and (F) P0 genes. Results represent the means ± SEM of at least four independent experiments. *P < 0.05 and ***P < 0.001 by Tukey's post hoc tests after one-way ANOVA compared with control. (G) MSC80 cells were transfected with siRNA directed against Ahr (siAhr) or a nontargeting siRNA (NT) for 48 h. Total proteins were extracted, and WBs were performed using antibodies against total β-catenin or active β-catenin and α-tubulin as a loading control. Figures represent a typical experiment. WB quantifications were done using ImageJ software. (H) Total RNA was extracted, and qRT-PCR experiments were performed using primers recognizing Lrp6, Dvl2, Dvl3, and Axin2. RT-PCR was normalized using 26S RNA. Data represent the mean ± SEM of at least four independent experiments. (I) MSC80 cells were transiently transfected with SuperTOP Flash-luciferase (STF-Luciferase) and with either siAHR or NT. Forty-eight hours later, luciferase activity was analyzed. Results represent the means ± SEM of at least six independent experiments performed in duplicate. *P < 0.05, **P < 0.01, by Student's t test. (J) Coimmunoprecipitation assays were performed on MSC80 cell extracts using AHR, blotted for β-catenin by WB, and lgG was used as a control. (K) The binding sites for TCF/LEF-β-catenin are localized on the promoter level for P0 and Pmp22 as described in ref. 12. MSC80 cells were transiently transfected with either siAhr or NT for 48 h after; ChIP assays with antibodies against β-catenin or Mock IgG or Histone H3 were peformed. Primers recognizing TCF/LEF-β-catenin binding sites on the levels of P0 (L) and Pmp22 (M) were used. Results represent the means ± SEM of at four independent experiments. *P < 0.05, ***P < 0.001 by Tukey's post hoc tests after one-way ANOVA compared with control.

Figure S2.

  Figure S2.

Fig. S2 .

 S2 Fig. S2. AHR inhibition causes apoptosis in the MPNST cell line. (A) The 90-8 cells were treated with either CH (50 μM, 48 h) or DMSO (vehicle). Total RNA was extracted and qRT-PCR experiments were performed using primers recognizing CYP1A1 and CYP1B1. Results were normalized to the TBP mRNA level. Results represent the means ± SEM of at least four independent experiments. *P < 0.05 by Student's t test. (B and C) The 90-8 cells were treated with either CH (50 μM, 48 h or 72 h) or DMSO (vehicle). At 48 h or 72 after treatment, cells were stained with Annexin and PI to detect cell death by flow cytometry: living cell population (Annexin V -/PI -), apoptotic cells (Annexin V + /PI), late apoptotic cells (Annexin V + /PI + ), and dead cells (Annexin V -/PI + ). Results represent the means ± SEM of at least four independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, by Bonferroni's post hoc tests after one-way ANOVA compared Legend continued on following page

Figure S3 .

 S3 Figure S3.

Fig. S5 .

 S5 Fig. S5. Uncropped WBs images of blots shown in the main figures. (A) Uncropped blots of 8WO mice (Fig.3N). (B) Uncropped blots of P7 mice (Fig.4E). (C) Uncropped blots of P21 mice (Fig.4J). (D) Uncropped blots of MSC80 (Fig.5G). (E) Uncropped blots for Co-IP (Fig.5J).

Table 1 : AHR pathway is dysregulated in nerve tumors. A,

 1 Total RNA was isolated from patients having dermal neurfibromas (n=8), Plexiform Neurofibromas (n=16), and MPNST (n=14). RT-qPCR were performed using primers recognizing specifically the genes indicated. Table indicates median [range] mRNA levels. mRNA levels were normalized such that the median value of the dermal neurofibromas was 1. Kruskal Wallis H test was used to compare MPNSTs vs plexiform neurofibromas vs dermal neurofibromas.

Table 2 : AHR is predominantly expressed in Schwann cells compared to mast cells and endothelial cells. A,

 2 Total RNA was isolated from normal human tissues. Tableindicatesmedian [range] mRNA levels. mRNA amounts (calculated as described in Materials and Methods) were normalized by using the endogenous control TBP transcript.

Table 1 .

 1 Median mRNA levels and ranges of 16 genes in dermal and PNFs and MPNSTs AHR pathway is dysregulated in nerve tumors. Total RNA was isolated from patients having dermal neurfibromas (n = 8), PNFs (n = 16), and MPNSTs (n = 14). qRT-PCR was performed using primers recognizing specifically the genes indicated. Table indicates median and range mRNA levels. mRNA levels were normalized such that the median value of the dermal neurofibromas was 1. Kruskal Wallis H test was used to compare MPNSTs vs. PNFs vs. dermal neurofibromas. NS, not significant. The bold values are statistically significant (P < 0.05). *Kruskal Wallis H test: MPNSTs vs. PNFs vs. dermal neurofibromas.

		Dermal neurofibromas,
			n = 8	PNFs, n = 16	MPNSTs, n = 14
	Genes	Median	Range	Median	Range	Median	Range	P*
	AHR pathway
	AHR	1.00	0.13-11.59	6.84	0.01-71.01	8.98	0.57-63.28	P < 0.05
	AHRR	1.00	0.56-8.44	0.39	0.13-1.60	0.49	0.07-1.80	P < 0.01
	ARNT	1.00	0.76-3.38	2.12	0.65-5.78	1.71	0.49-7.62	NS
	Trp metabolism
	IDO1	1.00	0.04-10.75	2.98	0.11-41.54	49.38	1.59-681.64	P < 0.01
	IDO2	1.00	0.21-6.74	0.60	0.07-5.06	0.65	0.01-18.21	NS
	TDO2	1.00	0.05-101.38	7.21	0.25-77.62	24.77	0.86-2,931.70	P < 0.01
	Myelin SCs
	S100B	1.00	0.64-1.73	0.82	0.10-4.49	0.02	0.01-2.54	P < 0.01
	MPZ	1.00	0.10-1.79	0.46	0.10-2.54	0.01	0.01-2.24	P < 0.01
	Inflammation
	IL-1B	1.00	0.26-4.09	19.44	0.01-809.67	6.15	2.66-644.12	P < 0.05
	IL-6	1.00	0.50-1.95	19.86	0.18-247.60	25.67	3.06-32.04	P < 0.05
	IL-8	1.00	0.07-3.15	8.98	0.01-648.32	13.65	0.19-269.89	P < 0.05
	CXCL5	1.00	0.08-40.19	32.42	0.01-643.00	185.53	0.17-25,864.45	P < 0.01
	CXCL6	1.00	0.01-5.66	10.86	2.28-1,642.39	24.33	4.60-862.02	P < 0.01
	Xenobiotics metabolism
	CYP1A1	1.00	0.01-1.88	2.16	0.10-18.85	1.50	0.40-4.11	NS
	CYP1B1	1.00	0.49-5.78	1.01	0.12-9.07	0.69	0.11-4.42	NS
	Proliferation
	MKI67	1.00	0.30-2.82	1.39	0.88-4.77	31.43	13.6-82.9	P < 0.01

Table 2 .

 2 Relative mRNA expression of eight genes in different human cells

	Genes	SCs	Mast cells	Endothelial cell
	AHR pathway
	AHR	426	11	6
	AHRR	200	1,342	78
	ARNT	1,105	492	479
	Trp metabolism
	IDO1	10	NE	2
	IDO2	NE	NE	NE
	TDO2	14	3	NE
	Myelin markers
	S100B	66,360	2	6
	MPZ	24,336	4	5

  AHR pathway is dysregulated in nerve tumors. Total RNA was isolated from patients having dermal neurfibromas (n = 8), PNFs (n = 16), and MPNSTs (n = 14). qRT-PCR was performed using primers recognizing specifically the genes indicated. Table indicates median and range mRNA levels. mRNA levels were normalized such that the median value of the dermal neurofibromas was 1. Kruskal Wallis H test was used to compare MPNSTs vs. PNFs vs. dermal neurofibromas. NS, not significant. The bold values are statistically significant (P < 0.05). *Kruskal Wallis H test: MPNSTs vs. PNFs vs. dermal neurofibromas.

	CYP1B1	1.00	01-1.88 0.49-5.78	2.16 1.01	0.10-18.85 0.12-9.07	1.50 0.69	0.40-4.11 0.11-4.42	NS NS
	Proliferation
	MKI67	1.00	0.30-2.82	1.39	0.88-4.77	31.43	13.6-82.9	P < 0.01
	Shackleford et al.

PNAS | Published online January 19, 2018 | E1321

Primers that are not listed here will be provided on request.


Marianne Stettler

M Siles-Lucas

Elisabeth Sarciron

Philippe Lawton

Bruno Gottstein

Andrew Hemphill

Echinococcus multilocularis Alkaline Phosphatase as a Marker for Metacestode Damage Induced by In Vitro Drug Treatment with Albendazole Sulfoxide and Albendazole Sulfone

de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.